[
    {
        "file_name": "musclepharmcorp_20170208_10-ka_ex-10.38_9893581_ex-10.38_co-branding agreement.pdf",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "(v)\tDuring the Term and during the sell-off period, MusclePharm shall make royalty payments in U.S. dollars for the respective quarters ending on the last day of September, December, March and June (each, a “Royalty Period”) within thirty (30) days from the end of each quarterly period.  Each such royalty payment shall include an itemized statement showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized statement shall be certified by a duly authorized officer of MusclePharm.  Such statements shall be in the form attached hereto as Exhibit “B” and furnished to Lender whether or not any Licensed Products were sold during the Royalty Period.",
                "changed_text": "(v)\tDuring the Term and during the sell-off period, MusclePharm shall make royalty payments in U.S. dollars for the respective quarters ending on the last day of September, December, March and June (each, a “Royalty Period”) within ninety (90) days from the end of each quarterly period.  Each such royalty payment shall include an itemized statement showing the nature and source of such royalties, including (i) the number of units of Licensed Products sold (by country and customer); (ii) the total number of units returned for which credit was given and the total dollar amount of such credits, and (iii) the total gross sales and the total royalties due with respect to such gross sales, and each itemized statement shall be certified by a duly authorized officer of MusclePharm.  Such statements shall be in the form attached hereto as Exhibit “B” and furnished to Lender whether or not any Licensed Products were sold during the Royalty Period.",
                "explanation": "California law requires royalty payments to be made in a more timely manner than 90 days following the end of each quarter, potentially violating California's prompt payment laws regarding royalties.",
                "contradicted_law": "California Labor Code Section 200 et seq.",
                "location": "Section 7(a)(v)"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "MusclePharm shall, throughout the Term of the Agreement and for a period of not less than four years thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability, in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds.",
                "changed_text": "MusclePharm shall, throughout the Term of the Agreement and for a period of not less than one year thereafter, obtain and maintain at its own cost and expense from a qualified insurance company licensed to do business in California and New York, a commercial general liability insurance policy including coverage for contractual liability (applying to the terms and conditions of this agreement), product liability, personal injury liability, and advertiser's liability, in a form approved by the AS Parties, in the amount of at least Five Million Dollars (US$5,000,000) per occurrence naming the AS Parties (for the avoidance of doubt, specifically including each of Lender, Endorser, and Fitness) as additional named insureds.",
                "explanation": "Reducing the insurance maintenance period to one year after the contract term might not comply with California's statutes of limitations for certain product liability or other claims, potentially exposing the AS Parties to uncovered liabilities beyond the one-year period.",
                "contradicted_law": "California Code of Civil Procedure Section 335 et seq.",
                "location": "Section 27"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "During the term of this Agreement and for three (3) years thereafter, each party shall hold in strict confidence all such information.  This obligation shall not apply to any information which: (a) becomes known to the general public through no fault of either party; (b) is required to be disclosed in the enforcement of rights hereunder, or (c) is required to be disclosed by any state or federal statue, regulation or court order.",
                "changed_text": "During the term of this Agreement and for one (1) year thereafter, each party shall hold in strict confidence all such information.  This obligation shall not apply to any information which: (a) becomes known to the general public through no fault of either party; (b) is required to be disclosed in the enforcement of rights hereunder, or (c) is required to be disclosed by any state or federal statue, regulation or court order.",
                "explanation": "Limiting the confidentiality period to one year may conflict with California's trade secret laws, which protect trade secrets for as long as they remain confidential and provide a longer period to pursue misappropriation claims.",
                "contradicted_law": "California Uniform Trade Secrets Act (Cal. Civ. Code § 3426 et seq.)",
                "location": "Section 26"
            }
        ]
    }
]